542771 — Novateor Research Laboratories Balance Sheet
0.000.00%
- IN₹202.55m
- IN₹209.27m
- IN₹12.07m
Annual balance sheet for Novateor Research Laboratories, fiscal year end - March 31st, INR millions except per share, conversion factor applied.
2020 March 31st | 2021 March 31st | 2022 March 31st | R2023 March 31st | 2024 March 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IAS | IAS | IAS | IAS | IAS |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 6.94 | 6.59 | 4.75 | 2.19 | 0.895 |
Net Total Accounts Receivable | |||||
Net Total Receivables | 2.49 | 2.48 | 6.19 | 7.02 | 11.2 |
Total Inventory | |||||
Total Other Current Assets | |||||
Total Current Assets | 51.4 | 54.9 | 61 | 64.9 | 75.2 |
Net Property, Plant And Equipment | 34.5 | 33.6 | 19.4 | 22.1 | 28.7 |
Long Term Investments | |||||
Other Long Term Assets | |||||
Total Assets | 87.9 | 89.7 | 81.4 | 89.5 | 105 |
Accounts Payable | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 0.519 | 1.1 | 0.515 | 7.31 | 12 |
Long Term Debt | |||||
Total Long Term Debt | |||||
Total Debt | |||||
Deferred Income Tax | |||||
Total Other Liabilities | |||||
Total Liabilities | 2.33 | 3.99 | 2.99 | 10.7 | 17 |
Common Stock | |||||
Retained Earnings (Accumulated Deficit) | |||||
Total Equity | 85.6 | 85.7 | 78.4 | 78.8 | 87.6 |
Total Liabilities & Shareholders' Equity | 87.9 | 89.7 | 81.4 | 89.5 | 105 |
Total Common Shares Outstanding |